Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Sotorasib bulk supplier for pharma manufacturers

Sotorasib 960 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 960 mg

Reference Brands: Lumakras (USA/EU)

Category: Oncology Cancer Care

Sotorasib (Lumakras) is used to treat adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC) who have received at least one prior systemic therapy. It works by selectively inhibiting the KRAS G12C protein, preventing cancer cell growth and proliferation, and thereby slowing disease progression.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Sotorasib — third party manufacturing & bulk supply

Sotorasib 960 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sotorasib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sotorasib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sotorasib →
Back to Listing

Frequently Asked Questions

Sotorasib is used to treat non-small cell lung cancer (NSCLC) with KRAS G12C mutations in patients who have received prior therapies.

Sotorasib is a small-molecule inhibitor that selectively targets the KRAS G12C mutant protein, blocking cancer cell growth.

The trade name is Lumakras.

Lumakras is manufactured by Amgen.

The generic name is sotorasib.

The brand name is Lumakras.

It is manufactured in the United States by Amgen.

Related Products

Mosunetuzumab-Axgb

Strength:
1 mg/mL

Form: Injection

Reference Brands: Lunsumio (USA/EU)

View Details
Lutetium Lu 177 Dotatate

Strength:
7.4 GBq/ vial

Form: Injection

Reference Brands: Lutathera (USA, EU)

View Details
Denileukin Diftitox

Strength:
300 mcg

Form: Injection

Reference Brands: Lymphir (USA/EU), Ontak (USA/EU)

View Details
Linvoseltamab-Gcpt

Strength:
5 mg/2.5 mL

Form: Injection

Reference Brands: Lynozyfic (USA/EU)

View Details
Azacitidine Injection

Strength:
100 mg/vial

Form: Injectable

Reference Brands: Vidaza®(EU & US)

View Details
Bendamustine Hydrochloride

Strength:
25 mg/vial, 100 mg/vial

Form: Injection (powder for solution)

Reference Brands: Treanda®, Bendeka®(US), Levact®(EU)

View Details
Bortezomib 2 Mg Injection

Strength:
1 mg/vial, 3.5 mg/vial, 2 mg

Form: Injection (lyophilized powder for solution)

Reference Brands: Velcade® (US & EU), Bortecad (India)

View Details
Busulfan

Strength:
Injection: 6 mg/mL; Tablet: 2 mg

Form: Injection (IV), Oral Tablet

Reference Brands: US: Busulfex® (IV), Myleran® (oral); EU: Busilvex® (IV), Myleran® (tablet)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.